Therapy Areas: Vaccines
Anixa Biosciences plans Phase 2 breast cancer vaccine study
25 September 2024 - California-based biotechnology company Anixa Biosciences Inc (NASDAQ: ANIX) announced on Tuesday its plan for a Phase 2 study of its breast cancer vaccine.The Phase 1 trial is bein...
MedImmune's FluMist nasal spray influenza vaccine receives US FDA approval
23 September 2024 - US-based MedImmune LLC announced on Friday that it has received approval from the US Food and Drug Administration (FDA) for FluMist, an influenza vaccine for self- or caregiver-adm...
Gavi signs agreement with Bavarian Nordic for Mpox vaccines
18 September 2024 - Denmark-based vaccines company Bavarian Nordic A/S (CPH:BAVA) announced on Wednesday an agreement with vaccine alliance Gavi to secure 500,000 doses of the MVA-BN mpox vaccine (mar...
Valneva seeks label extensions for chikungunya vaccine in Europe and Canada
18 September 2024 - Vaccine company Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) said on Wednesday that it has submitted label extension applications to the European Medicines Agency (EMA) and Health...
MinervaX and Wacker Biotech collaborate on GBS vaccine manufacturing
17 September 2024 - Danish biotechnology company MinervaX ApS and Wacker Biotech, a contract development and manufacturing organisation (CDMO) owned by German chemical company Wacker Chemie AG (ETR:WC...
Merck's GARDASIL 9 shows promise in preventing HPV infection in Japanese males
11 September 2024 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, on Wednesday announced positive top-line results from a Phase 3 trial evaluating it...